company-logo

SciBase Holding AB (publ), a medical technology company, develops and sells instruments for the detection of skin cancer and other skin conditions in Europe and internationally. Its product includes Nevisense and Nevisense Go, a point of care platform that addresses in the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. The company has a collaboration agreement with Advanced Dermatology and Cosmetic Surgery (ADCS) group. SciBase Holding AB (publ) was founded in 1998 and is headquartered in Sundbyberg, Sweden.

SciBase Dividend Announcement

SciBase does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on SciBase dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

SciBase Dividend History

SciBase Dividend Yield

SciBase current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing SciBase stock? Use our calculator to estimate your expected dividend yield:

SciBase Financial Ratios

P/E ratio-1.47
PEG ratio0.04
P/B ratio1.64
ROE-127.53%
Payout ratio0.00%
Current ratio3.71
Quick ratio3.11
Cash Ratio2.41

SciBase Dividend FAQ

Does SciBase stock pay dividends?
SciBase does not currently pay dividends to its shareholders.
Has SciBase ever paid a dividend?
No, SciBase has no a history of paying dividends to its shareholders. SciBase is not known for its dividend payments.
Why doesn't SciBase pay dividends?
There are several potential reasons why SciBase would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will SciBase ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While SciBase has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is SciBase a dividend aristocrat?
SciBase is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is SciBase a dividend king?
SciBase is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is SciBase a dividend stock?
No, SciBase is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy SciBase stocks?
To buy SciBase you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy SciBase stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.